Clinico-pathological conferences. 6, My husband thinks it's nerves : a problem of diagnosis.

Part 1 is entitled 'Amanda Selby presents to the General Practitioner'. Amanda Selby returns from a visit to the GP and argues with her husband who accuses her of being a hypochondriac. At a subsequent visit to the GP she has developed a skin reaction. Her case reveals various mensturation and joint problems as well as other aches and pains. Part 2 is entitled The Consultant takes a history. Amanda refers Amanda to Dr Ann Whitehead in the Department of Rheumatology. Amanda talks about her childhood; she lost her mother as a teenager and complains of joint pains and headaches. She talks about her early career a laboratory technician and then as an air hostess. Part 3 is the consultant's examination. Amanda explains her visit to the consultant to her unsympathetic husband. The consultant breaks the news that Amanda has a relatively rare condition... Part 4 The Diagnosis is presented by Dr Carol Black, Consultant Rheumatologist, West Middlesex University Hospital. Dr Black talks about the difficulty of diagnosis in connective tissue diseases. A real patient with rheumatoid arthritis describes her symptoms. An infomercial for Voltoral Retard, an anti-inflamatory treatment, is inserted. Part 4 The Diagnosis, also presented by Dr Carol Black, looks at Systemic Lupus and Erythematosus. A patient with these conditions describes the symptoms. An infomercial for Voltoral Retard, an anti-inflamatory treatment, is inserted. Part 4 The Diagnosis also presented by Dr Carol Black, looks at further alternative diagnoses; mixed connective tissue disease, polymyositis, dermatomyositis. Patients with these conditions describe the symptoms. An infomercial for Voltoral Retard, an anti-inflamatory treatment, is inserted. Part 4 The Diagnosis: Dr Black reviews all the case studies especially her history. The final diagnosis is scleroderma; the patient which this case story was based upon talks about her condition. An infomercial for Voltoral Retard, an anti-inflamatory treatment, ends the programme.